Form 4: BioLife Solutions CMO Sells 10,000 Shares
Insider Transaction Report
BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 10,000 shares of common stock for approximately $25.53 per share in a pre-planned transaction.
Summary
- Todd Berard, Chief Marketing Officer of BioLife Solutions Inc. (BLFS), sold 10,000 shares of the company's common stock.
- The transaction took place on August 25, 2025.
- The shares were sold at a weighted average price of $25.53 per share, with individual transaction prices ranging from $25.46 to $25.63.
- Following this sale, Mr. Berard beneficially owns 124,618 shares of BioLife Solutions common stock.
- The sale was executed pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
Sentiment
Score: 5
Explanation: The sale by the Chief Marketing Officer is a routine disclosure for an insider transaction. While insider selling can sometimes be viewed negatively, the transaction was executed under a Rule 10b5-1 pre-arranged trading plan, which suggests it was not based on new, non-public information, thus making the sentiment neutral.
Negatives
- The sale of 10,000 shares by Chief Marketing Officer Todd Berard, while pre-planned, could be perceived by some investors as a neutral to slightly negative signal regarding insider sentiment.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: May view the insider sale as a routine event due to the 10b5-1 plan, or as a minor signal of insider sentiment, though unlikely to significantly alter investment theses on its own.
Key Dates
| Date | Description |
|---|---|
| 08/25/2025 | Date of common stock transaction by Todd Berard. |
| 08/27/2025 | Date the Form 4 was signed and filed. |
Recommendation
holdThe Form 4 reports a routine, pre-planned insider sale under a Rule 10b5-1 plan. This type of transaction is generally not indicative of a significant change in the company's fundamental outlook or a strong signal for immediate investment action. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide sufficient new information to alter an existing investment thesis.
Keywords
BioLife Solutions, BLFS, Insider Trading, Form 4, Stock Sale, Todd Berard, Chief Marketing Officer, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.